CoChat

Structural conservation of antibiotic interaction with ribosomes

Open access

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.

Abstract

The ribosome is a major target for clinically used antibiotics, but multidrug resistant pathogenic bacteria are making our current arsenal of antimicrobials obsolete. Here we present cryo-electron-microscopy structures of 17 distinct compounds from six different antibiotic classes bound to the bacterial ribosome at resolutions ranging from 1.6 to 2.2 Å. The improved resolution enables a precise description of antibiotic–ribosome interactions, encompassing solvent networks that mediate multiple additional interactions between the drugs and their target. Our results reveal a high structural conservation in the binding mode between antibiotics with the same scaffold, including ordered water molecules. Water molecules are visualized within the antibiotic binding sites that are preordered, become ordered in the presence of the drug and that are physically displaced on drug binding. Insight into RNA–ligand interactions will facilitate development of new antimicrobial agents, as well as other RNA-targeting therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41594-023-01047-y

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Cryo-EM maps and models for 17 ribosome-targeting antibiotics. Segmented cryo-EM map densities (transparent gray) and molecule models (colored by atom) are shown for tetracyclines (tetracycline, omadacycline, eravacycline and pentacycline), aminoglycosides (hygromycin B, gentamicin, spectinomycin, streptomycin, apramycin and kasugamycin), tuberactinomycin (capreomycin), orthosomycin (avilamycin and evernimicin), pleuromutilin (tiamulin and retapamulin) and lincosamide (lincomycin and clindamycin) antibiotics.
Fig. 1 Cryo-EM maps and models for 17 ribosome-targeting antibiotics. Segmented cryo-EM map densities (transparent gray) and molecule models (colored by atom) are shown for tetracyclines (tetracycline, omadacycline, eravacycline and pentacycline), aminoglycosides (hygromycin B, gentamicin, spectinomycin, streptomycin, apramycin and kasugamycin), tuberactinomycin (capreomycin), orthosomycin (avilamycin and evernimicin), pleuromutilin (tiamulin and retapamulin) and lincosamide (lincomycin and clindamycin) antibiotics.CC BY · PubMed Central
Fig. 2 Structures of antibiotics targeting the SSU. The central ring shows a superimposition of the binding sites on the SSU (gray) of the antibiotics tetracycline (blue), spectinomycin (yellow), hygromycin B (pink), kasugamycin (red), apramycin (green), gentamicin (cyan) and streptomycin (orange), which is surrounded by insets highlighting the interactions between the drug and the 16S rRNA (gray), waters (red spheres with gray transparent density), magnesium ions (green spheres), putative K+ ions (purple sphere with transparent gray density) and uS12 (orange). Potential hydrogen bonds are indicated as dashed lines, colored orange for direct interaction between the drug and the small subunit, cyan for water-mediated interactions, green for Mg2+ ion coordination and purple for K+ coordination.
Fig. 2 Structures of antibiotics targeting the SSU. The central ring shows a superimposition of the binding sites on the SSU (gray) of the antibiotics tetracycline (blue), spectinomycin (yellow), hygromycin B (pink), kasugamycin (red), apramycin (green), gentamicin (cyan) and streptomycin (orange), which is surrounded by insets highlighting the interactions between the drug and the 16S rRNA (gray), waters (red spheres with gray transparent density), magnesium ions (green spheres), putative K+ ions (purple sphere with transparent gray density) and uS12 (orange). Potential hydrogen bonds are indicated as dashed lines, colored orange for direct interaction between the drug and the small subunit, cyan for water-mediated interactions, green for Mg2+ ion coordination and purple for K+ coordination.CC BY · PubMed Central
Fig. 3 Structures of antibiotics targeting the interface and LSU. The central ring shows a superimposition of the binding sites on the LSU (gray) of the antibiotics capreomycin (green), avilamycin (blue), lincomycin (red) and tiamulin (yellow), which is surrounded by insets highlighting the interactions between the drug and the rRNA (gray), waters (red spheres with gray transparent density), putative K+ ions (purple sphere with transparent gray density) and uL16 (orange). Potential hydrogen bonds are indicated as dashed lines, colored orange for direct interaction between the drug and the small subunit, cyan for water-mediated interactions, green for Mg2+ ion coordination and purple for K+ coordination.
Fig. 3 Structures of antibiotics targeting the interface and LSU. The central ring shows a superimposition of the binding sites on the LSU (gray) of the antibiotics capreomycin (green), avilamycin (blue), lincomycin (red) and tiamulin (yellow), which is surrounded by insets highlighting the interactions between the drug and the rRNA (gray), waters (red spheres with gray transparent density), putative K+ ions (purple sphere with transparent gray density) and uL16 (orange). Potential hydrogen bonds are indicated as dashed lines, colored orange for direct interaction between the drug and the small subunit, cyan for water-mediated interactions, green for Mg2+ ion coordination and purple for K+ coordination.CC BY · PubMed Central
Fig. 4 Structural conservation of antibiotic binding to ribosomes. a, Interaction of streptomycin (StrA) on the SSU at 2.0 Å. b, Superimposition of streptomycin (StrA) from a with streptomcyin (StrB) determined at 1.8 Å (from Fig. 2). c, Superimposition of streptomycin determined here on E. coli (StrEco) at 1.8 Å (StrB from Fig. 2) with streptomycin on the human mitochondrial SSU body (Strmito) at 2.23 Å (ref. 11). d,e, Interaction of eravacycline (Era) (d) and omadacycline (e) on the SSU at 2.1 and 2.2 Å, respectively. f, Superimposition of eravacycline (Era) from d, omadacycline from (and tetracycline (Tet) (from Fig. 2). g, Interaction of clindamycin (Cln) on the LSU at 2.0 Å. h, Superimposition of clindamycin (Cln) from g with lincomycin (Lnc) determined at 1.6 Å (from Fig. 3). i, Superimposition of lincomycin determined here on E. coli (LncEco) at 1.8 Å (from Fig. 2) with lincomycin on the L. monocytogenes 70S ribosome (LncLm. at 2.1 Å, ref. 47). j, Interaction of retapamulin (Ret) on the LSU at 1.9 Å. k, Superimposition of retapamulin (Ret) from j with tiamulin (Tia) (from Fig. 3). l, Superimposition of Ret (blue) and 23S rRNA (cyan) from Ret-LSU structure with E. coli 70S ribosome lacking any drug in the A-site of the PTC (gray, PDB ID 7K00)12.
Fig. 4 Structural conservation of antibiotic binding to ribosomes. a, Interaction of streptomycin (StrA) on the SSU at 2.0 Å. b, Superimposition of streptomycin (StrA) from a with streptomcyin (StrB) determined at 1.8 Å (from Fig. 2). c, Superimposition of streptomycin determined here on E. coli (StrEco) at 1.8 Å (StrB from Fig. 2) with streptomycin on the human mitochondrial SSU body (Strmito) at 2.23 Å (ref. 11). d,e, Interaction of eravacycline (Era) (d) and omadacycline (e) on the SSU at 2.1 and 2.2 Å, respectively. f, Superimposition of eravacycline (Era) from d, omadacycline from (and tetracycline (Tet) (from Fig. 2). g, Interaction of clindamycin (Cln) on the LSU at 2.0 Å. h, Superimposition of clindamycin (Cln) from g with lincomycin (Lnc) determined at 1.6 Å (from Fig. 3). i, Superimposition of lincomycin determined here on E. coli (LncEco) at 1.8 Å (from Fig. 2) with lincomycin on the L. monocytogenes 70S ribosome (LncLm. at 2.1 Å, ref. 47). j, Interaction of retapamulin (Ret) on the LSU at 1.9 Å. k, Superimposition of retapamulin (Ret) from j with tiamulin (Tia) (from Fig. 3). l, Superimposition of Ret (blue) and 23S rRNA (cyan) from Ret-LSU structure with E. coli 70S ribosome lacking any drug in the A-site of the PTC (gray, PDB ID 7K00)12.CC BY · PubMed Central
Fig. 5 Temperature-dependent dynamics of lincomycin and waters obtained from MD simulations. a, Fluctuations of atom positions in simulations at different temperatures are quantified by r.m.s.f. for all lincomycin atoms (Lnc), for the galactopyranoside sugar (GS) and the propyl-pyrrolidinyl tail (PT). Structural deviations of average MD structures from cryo-EM structure are quantified by r.m.s.d. Circles and lines indicate median values and 95% confidence intervals obtained from ten independent simulations. b, Molecular model of lincomycin, surrounding rRNA nucleotides and waters (black spheres) within hydrogen bond distance resolved by cryo-EM. Average water positions (solid red spheres) and their r.m.s.f. (radius of transparent red spheres) obtained from MD simulations at 37 °C are shown. c, The r.m.s.f. for each water shown in b and distances between positions in cryo-EM and MD simulations. Median and confidence intervals as described in a. d, same view as b, but with cryo-EM density (transparent) shown for water molecules. e, Neural network to predict r.m.s.d. of lincomycin from occupancies of hydrogen bonds hn(t) f, The r.m.s.d. of lincomycin obtained from MD simulations (black lines) and predicted by neural networks trained on occupancies of direct, indirect or direct and indirect hydrogen bonds (colors). Data used for training and cross-validation are indicated. R.m.s.e. between r.m.s.d. values predicted from the neural network and obtained from simulation. g, Mean (circles) and standard deviations (lines) of r.m.s.e. for training and cross-validation for ten independent neural networks with different sets of training and cross-validation data.
Fig. 5 Temperature-dependent dynamics of lincomycin and waters obtained from MD simulations. a, Fluctuations of atom positions in simulations at different temperatures are quantified by r.m.s.f. for all lincomycin atoms (Lnc), for the galactopyranoside sugar (GS) and the propyl-pyrrolidinyl tail (PT). Structural deviations of average MD structures from cryo-EM structure are quantified by r.m.s.d. Circles and lines indicate median values and 95% confidence intervals obtained from ten independent simulations. b, Molecular model of lincomycin, surrounding rRNA nucleotides and waters (black spheres) within hydrogen bond distance resolved by cryo-EM. Average water positions (solid red spheres) and their r.m.s.f. (radius of transparent red spheres) obtained from MD simulations at 37 °C are shown. c, The r.m.s.f. for each water shown in b and distances between positions in cryo-EM and MD simulations. Median and confidence intervals as described in a. d, same view as b, but with cryo-EM density (transparent) shown for water molecules. e, Neural network to predict r.m.s.d. of lincomycin from occupancies of hydrogen bonds hn(t) f, The r.m.s.d. of lincomycin obtained from MD simulations (black lines) and predicted by neural networks trained on occupancies of direct, indirect or direct and indirect hydrogen bonds (colors). Data used for training and cross-validation are indicated. R.m.s.e. between r.m.s.d. values predicted from the neural network and obtained from simulation. g, Mean (circles) and standard deviations (lines) of r.m.s.e. for training and cross-validation for ten independent neural networks with different sets of training and cross-validation data.CC BY · PubMed Central
Extended Data Fig. 1 Comparison of structures of antibiotic-ribosome complexes. a-k, Superimposition of previous structures of diverse antibiotic-ribosome complexes, including (a) gentamicin (yellow) on the E. coli 70S ribosome at 3.5 Å (PDB ID 4V53)28 with gentamicin (green) on the T. thermophilus 30S at 3.3 Å (PDB ID 4LF9), (b) kasugamycin (yellow) on the E. coli 70S ribosome at 3.5 Å (PDB ID 4V4H)89 with kasugamycin (red) on the T. thermophilus 30S at 3.4 Å (PDB ID 2HHH)30, (c) streptomycin on the T. thermophilus 30S at 3.0 Å (yellow; PDB ID 1FJG)90 at 3.3 Å (green, PDB ID 4DR6)91 at 3.35 Å (blue, PDB ID 4JI1)91 with streptomycin (red) on the human mitochondrial small subunit at 2.4 Å (PDB ID 7P2E)92, (d) apramycin (yellow) on the T. thermophilus 30S at 3.5 Å (PDB ID 4AQY)29 with apramycin on the E. coli 70S ribosome at 2.4 Å (red, PDB ID 7PJS)7 and 3.1 Å (green, PDB ID 7PJV)7, (e) hygromycin B on the T. thermophilus 30S at 3.3 Å (yellow, PDB ID 1HNZ)26 and 3.7 Å (blue, PDB ID 4LFA) with hygromycin B on the E. coli 70S ribosome at 3.5 Å (red, PDB ID 4V64)37, (f) spectinomycin (red) on the T. thermophilus 30S at 3.0 Å (PDB ID 1FJG)90 with spectinomycin on E. coli 70S ribosome at 3.5 Å (green, PDB ID 4V57)28, E. faecalis 70S ribosome at 2.4 Å (yellow, PDB ID 7P7Q)8 and within an E. coli 70S translocation intermediate at 2.5 Å (blue, PDB ID 7N2V)55, (g) tetracycline on the T. thermophilus 30S at 3.4 Å (red, PDB ID 1HNW)26 and 4.5 Å (yellow, PDB ID 1I97)27 with tetracycline (blue) on the T. thermophilus 70S at 3.3 Å (PDB ID 4V9A)93 and tetracycline (green) on the E. coli 70S at 2.8 Å (PDB ID 5J5B)94, (h) the pleuromutilins tiamulin (yellow) on the D. radiodurans 50S at 3.5 Å (PDB ID 1XBP)50, retapamulin (blue) on the D. radiodurans 50S at 3.7 Å (PDB ID 2OGO)51, tiamulin (red) on the archaeal H. marismortui 50S at 3.2 Å (PDB ID 3G4S)49 and lefamulin (green) on the S. aureus 50S at 3.6 Å (PDB ID 5HL7)53, (i) capreomycin (yellow) on the T. thermophilus 70S at 3.5 Å (PDB ID 4V7M)32 with capreomycin (red) on the M. tuberculosis 70S at 4.0 Å (PDB ID 5V93)95, (j) the orthosomycins avilamycin (blue, PDB ID 5KCR) and evernimicin (red, PDB ID 5KCS) on the E. coli 70S at 3.9 Å43 with avilamycin (green, PDB ID 5JVG) and evernimicin (yellow, PDB ID 5JVH) on the D. radiodurans 50S at at 3.6 Å and 3.4 Å, respectively44, (k) the lincosamide clindamycin on the D. radiodurans 50S at 3.1 Å (yellow, PDB ID 1JZY)96, on the H. marismortui 50S at 3.0 Å (red, PDB ID 1YJN)97 and on the E. coli 70S at 3.3 Å (green, PDB ID 4V7V)98 with lincomycin on the S. aureus 50S at 3.7 Å (blue, PDB ID 5HKV)99. Alignments were made using the rRNA within 10 Å of the antibiotic. rRNA and r-proteins comprising the binding site are colored grey, whereas antibiotics (including waters and ions if present) are color-coded as indicated.
Extended Data Fig. 1 Comparison of structures of antibiotic-ribosome complexes. a-k, Superimposition of previous structures of diverse antibiotic-ribosome complexes, including (a) gentamicin (yellow) on the E. coli 70S ribosome at 3.5 Å (PDB ID 4V53)28 with gentamicin (green) on the T. thermophilus 30S at 3.3 Å (PDB ID 4LF9), (b) kasugamycin (yellow) on the E. coli 70S ribosome at 3.5 Å (PDB ID 4V4H)89 with kasugamycin (red) on the T. thermophilus 30S at 3.4 Å (PDB ID 2HHH)30, (c) streptomycin on the T. thermophilus 30S at 3.0 Å (yellow; PDB ID 1FJG)90 at 3.3 Å (green, PDB ID 4DR6)91 at 3.35 Å (blue, PDB ID 4JI1)91 with streptomycin (red) on the human mitochondrial small subunit at 2.4 Å (PDB ID 7P2E)92, (d) apramycin (yellow) on the T. thermophilus 30S at 3.5 Å (PDB ID 4AQY)29 with apramycin on the E. coli 70S ribosome at 2.4 Å (red, PDB ID 7PJS)7 and 3.1 Å (green, PDB ID 7PJV)7, (e) hygromycin B on the T. thermophilus 30S at 3.3 Å (yellow, PDB ID 1HNZ)26 and 3.7 Å (blue, PDB ID 4LFA) with hygromycin B on the E. coli 70S ribosome at 3.5 Å (red, PDB ID 4V64)37, (f) spectinomycin (red) on the T. thermophilus 30S at 3.0 Å (PDB ID 1FJG)90 with spectinomycin on E. coli 70S ribosome at 3.5 Å (green, PDB ID 4V57)28, E. faecalis 70S ribosome at 2.4 Å (yellow, PDB ID 7P7Q)8 and within an E. coli 70S translocation intermediate at 2.5 Å (blue, PDB ID 7N2V)55, (g) tetracycline on the T. thermophilus 30S at 3.4 Å (red, PDB ID 1HNW)26 and 4.5 Å (yellow, PDB ID 1I97)27 with tetracycline (blue) on the T. thermophilus 70S at 3.3 Å (PDB ID 4V9A)93 and tetracycline (green) on the E. coli 70S at 2.8 Å (PDB ID 5J5B)94, (h) the pleuromutilins tiamulin (yellow) on the D. radiodurans 50S at 3.5 Å (PDB ID 1XBP)50, retapamulin (blue) on the D. radiodurans 50S at 3.7 Å (PDB ID 2OGO)51, tiamulin (red) on the archaeal H. marismortui 50S at 3.2 Å (PDB ID 3G4S)49 and lefamulin (green) on the S. aureus 50S at 3.6 Å (PDB ID 5HL7)53, (i) capreomycin (yellow) on the T. thermophilus 70S at 3.5 Å (PDB ID 4V7M)32 with capreomycin (red) on the M. tuberculosis 70S at 4.0 Å (PDB ID 5V93)95, (j) the orthosomycins avilamycin (blue, PDB ID 5KCR) and evernimicin (red, PDB ID 5KCS) on the E. coli 70S at 3.9 Å43 with avilamycin (green, PDB ID 5JVG) and evernimicin (yellow, PDB ID 5JVH) on the D. radiodurans 50S at at 3.6 Å and 3.4 Å, respectively44, (k) the lincosamide clindamycin on the D. radiodurans 50S at 3.1 Å (yellow, PDB ID 1JZY)96, on the H. marismortui 50S at 3.0 Å (red, PDB ID 1YJN)97 and on the E. coli 70S at 3.3 Å (green, PDB ID 4V7V)98 with lincomycin on the S. aureus 50S at 3.7 Å (blue, PDB ID 5HKV)99. Alignments were made using the rRNA within 10 Å of the antibiotic. rRNA and r-proteins comprising the binding site are colored grey, whereas antibiotics (including waters and ions if present) are color-coded as indicated.CC BY · PubMed Central
Extended Data Fig. 2 Resolution of antibiotic-SSU head maps. a-e, Fourier-shell correlation (FSC) curve of the focused refined antibiotic-SSU head maps for (a) dataset 1, (b) dataset 2, (c) dataset 3, (d) dataset 4, and (e) dataset 5. The different curves include the masked map (green), unmasked map (blue) and the phase−randomized masked map (red). The dashed line at FSC 0.143 indicates that the average resolution for the SSU head maps for datasets 1–5 are 2.06 Å, 2.11 Å, 1.82 Å, 2.20 Å, 1.89 Å, respectively. f-j, Transverse section of the SSU head colored by local resolution for the focused refined maps calculated from (f) dataset 1, (g) dataset 2, (h) dataset 3, (i) dataset 4, and (j) dataset 5.
Extended Data Fig. 2 Resolution of antibiotic-SSU head maps. a-e, Fourier-shell correlation (FSC) curve of the focused refined antibiotic-SSU head maps for (a) dataset 1, (b) dataset 2, (c) dataset 3, (d) dataset 4, and (e) dataset 5. The different curves include the masked map (green), unmasked map (blue) and the phase−randomized masked map (red). The dashed line at FSC 0.143 indicates that the average resolution for the SSU head maps for datasets 1–5 are 2.06 Å, 2.11 Å, 1.82 Å, 2.20 Å, 1.89 Å, respectively. f-j, Transverse section of the SSU head colored by local resolution for the focused refined maps calculated from (f) dataset 1, (g) dataset 2, (h) dataset 3, (i) dataset 4, and (j) dataset 5.CC BY · PubMed Central
Extended Data Fig. 3 Resolution of antibiotic-SSU body maps. a-e, Fourier-shell correlation (FSC) curve of the focused refined SSU body maps for (a) dataset 1, (b) dataset 2, (c) dataset 3, (d) dataset 4, and (e) dataset 5. The different curves include the masked map (green), unmasked map (blue) and the phase−randomized masked map (red). The dashed line at FSC 0.143 indicates that the average resolution for the SSU body maps for datasets 1–5 are 2.08 Å, 2.04 Å, 1.79 Å, 2.12 Å, 1.89 Å, respectively. f-j, Transverse section of the SSU body coloured by local resolution for the focused refined maps calculated from (f) dataset 1, (g) dataset 2, (h) dataset 3, (i) dataset 4, and (j) dataset 5.
Extended Data Fig. 3 Resolution of antibiotic-SSU body maps. a-e, Fourier-shell correlation (FSC) curve of the focused refined SSU body maps for (a) dataset 1, (b) dataset 2, (c) dataset 3, (d) dataset 4, and (e) dataset 5. The different curves include the masked map (green), unmasked map (blue) and the phase−randomized masked map (red). The dashed line at FSC 0.143 indicates that the average resolution for the SSU body maps for datasets 1–5 are 2.08 Å, 2.04 Å, 1.79 Å, 2.12 Å, 1.89 Å, respectively. f-j, Transverse section of the SSU body coloured by local resolution for the focused refined maps calculated from (f) dataset 1, (g) dataset 2, (h) dataset 3, (i) dataset 4, and (j) dataset 5.CC BY · PubMed Central
Extended Data Fig. 4 Resolution of antibiotic-LSU maps. a-e, Fourier-shell correlation (FSC) curve of the focused refined LSU maps for (a) dataset 1, (b) dataset 2, (c) dataset 3, (d) dataset 4, and (e) dataset 5. The different curves include the masked map (green), unmasked map (blue) and the phase-randomized masked map (red). The dashed line at FSC 0.143 indicates that the average resolution for the LSU maps for datasets 1–5 are 1.86 Å, 1.83 Å, 1.64 Å, 1.98 Å, 1.65 Å, respectively. f-j, Transverse section of the LSU coloured by local resolution for the focused refined maps calculated from (f) dataset 1, (g) dataset 2, (h) dataset 3, (i) dataset 4, and (j) dataset 5.
Extended Data Fig. 4 Resolution of antibiotic-LSU maps. a-e, Fourier-shell correlation (FSC) curve of the focused refined LSU maps for (a) dataset 1, (b) dataset 2, (c) dataset 3, (d) dataset 4, and (e) dataset 5. The different curves include the masked map (green), unmasked map (blue) and the phase-randomized masked map (red). The dashed line at FSC 0.143 indicates that the average resolution for the LSU maps for datasets 1–5 are 1.86 Å, 1.83 Å, 1.64 Å, 1.98 Å, 1.65 Å, respectively. f-j, Transverse section of the LSU coloured by local resolution for the focused refined maps calculated from (f) dataset 1, (g) dataset 2, (h) dataset 3, (i) dataset 4, and (j) dataset 5.CC BY · PubMed Central
Extended Data Fig. 5 Secondary binding sites of antibiotics on the ribosome. a, Overview of the primary (1.) and secondary (2.) binding sites of tetracycline (blue) on the SSU determined here (left) and tetracycline (red) reported previously on the SSU (right, PDB ID 1HNW)26, with boxed zooms revealing the inverse orientation of tetracycline and distinct interactions observed with the rRNA. b, primary (1.) and secondary (2.-3.) binding sites of eravacycline/pentacycline (blue/cyan) on the SSU and LSU (left), compared with sites (red/orange) reported previously for eravacycline on the LSU (right)(PDB ID 7M4V)31. c, primary (1.) and secondary (2.-4.) binding sites of apramycin (blue) on the SSU and LSU (left), compared with sites reported previously on the LSU (right)(PDB ID 4AQY and 7PJS)7,29. d, primary (1.) and secondary (2.-3.) binding sites of gentamicin (blue) on the SSU (right), compared with sites reported previously for gentamicin (red/orange) on the SSU (right)(PDB ID 4V53))28. e, primary (1.) and secondary (2.-3.) binding sites of hygromycin B (blue) on the SSU (left), with insets showing the similarity in the coordination of a putative K+ ion in the primary and 3rd site. f, primary (1.) and secondary (2.-4.) binding sites of capreomycin (blue) on the SSU and LSU (left), compared with sites reported previously for viomycin on the SSU (right)(PDB ID 6LKQ)33.
Extended Data Fig. 5 Secondary binding sites of antibiotics on the ribosome. a, Overview of the primary (1.) and secondary (2.) binding sites of tetracycline (blue) on the SSU determined here (left) and tetracycline (red) reported previously on the SSU (right, PDB ID 1HNW)26, with boxed zooms revealing the inverse orientation of tetracycline and distinct interactions observed with the rRNA. b, primary (1.) and secondary (2.-3.) binding sites of eravacycline/pentacycline (blue/cyan) on the SSU and LSU (left), compared with sites (red/orange) reported previously for eravacycline on the LSU (right)(PDB ID 7M4V)31. c, primary (1.) and secondary (2.-4.) binding sites of apramycin (blue) on the SSU and LSU (left), compared with sites reported previously on the LSU (right)(PDB ID 4AQY and 7PJS)7,29. d, primary (1.) and secondary (2.-3.) binding sites of gentamicin (blue) on the SSU (right), compared with sites reported previously for gentamicin (red/orange) on the SSU (right)(PDB ID 4V53))28. e, primary (1.) and secondary (2.-3.) binding sites of hygromycin B (blue) on the SSU (left), with insets showing the similarity in the coordination of a putative K+ ion in the primary and 3rd site. f, primary (1.) and secondary (2.-4.) binding sites of capreomycin (blue) on the SSU and LSU (left), compared with sites reported previously for viomycin on the SSU (right)(PDB ID 6LKQ)33.CC BY · PubMed Central
Extended Data Fig. 6 Coordination of magnesium ions by tetracyclines. a-c, Coordination of (a) Mg1 (green) and (b) Mg2 by tetracycline (blue) and waters (red balls) and phosphate-oxygens of 16S rRNA determined here, compared with (c) previous structures PDB ID 1I9727, 1HNW26, 4V9A93, 5J5B94 and 5J7L94. Distances are provided for the green dashed lines. d-f, Coordination of (d) Mg1 (green) and (e) Mg2 by eravacycline (blue) and waters (red spheres) and phosphate-oxygens of 16S rRNA determined here, compared with (f) previous structures of eravacycline (PDB ID 7M4W)31 and tigecycline (PDB ID 4V9B93, 4YHH100, 5J9194 and 6YTF101). Distances are provided for the green dashed lines.
Extended Data Fig. 6 Coordination of magnesium ions by tetracyclines. a-c, Coordination of (a) Mg1 (green) and (b) Mg2 by tetracycline (blue) and waters (red balls) and phosphate-oxygens of 16S rRNA determined here, compared with (c) previous structures PDB ID 1I9727, 1HNW26, 4V9A93, 5J5B94 and 5J7L94. Distances are provided for the green dashed lines. d-f, Coordination of (d) Mg1 (green) and (e) Mg2 by eravacycline (blue) and waters (red spheres) and phosphate-oxygens of 16S rRNA determined here, compared with (f) previous structures of eravacycline (PDB ID 7M4W)31 and tigecycline (PDB ID 4V9B93, 4YHH100, 5J9194 and 6YTF101). Distances are provided for the green dashed lines.CC BY · PubMed Central
Extended Data Fig. 7 Displacement of waters upon antibiotic binding. a, View of tetracycline binding site (16S rRNA, grey) in the absence (left panel) and presence of tetracycline (right panel). Waters (spheres) that are displaced upon tetracycline (Tet, blue) binding are colored red. b, View of streptomycin binding site (16S rRNA, grey) in the absence (left panel) and presence of streptomycin (right panel). Waters (spheres) that are displaced upon streptomycin (Str, blue) binding are colored red. c, View of spectinomycin binding site (16S rRNA, grey) in the absence (left panel) and presence of spectinomycin (right panel). Waters (spheres) that are displaced upon spectinomycin (Spc, blue) binding are colored red. d, View of kasugamycin binding site (16S rRNA, grey) in the absence (left panel) and presence of kasugamycin (right panel). Waters (spheres) that are displaced upon kasugamycin (Ksg, blue) binding are colored red. e-h, View of (e) lincomycin, (f) clindamycin, (g) tiamulin and (h) retapamulin binding site (23S rRNA, grey) in the absence (left panel) and presence of the drug (right panel). Waters (spheres) that are displaced upon binding of the antibiotic are colored red. In (a)-(h), waters (spheres) that are stabilized upon drug binding are colored green.
Extended Data Fig. 7 Displacement of waters upon antibiotic binding. a, View of tetracycline binding site (16S rRNA, grey) in the absence (left panel) and presence of tetracycline (right panel). Waters (spheres) that are displaced upon tetracycline (Tet, blue) binding are colored red. b, View of streptomycin binding site (16S rRNA, grey) in the absence (left panel) and presence of streptomycin (right panel). Waters (spheres) that are displaced upon streptomycin (Str, blue) binding are colored red. c, View of spectinomycin binding site (16S rRNA, grey) in the absence (left panel) and presence of spectinomycin (right panel). Waters (spheres) that are displaced upon spectinomycin (Spc, blue) binding are colored red. d, View of kasugamycin binding site (16S rRNA, grey) in the absence (left panel) and presence of kasugamycin (right panel). Waters (spheres) that are displaced upon kasugamycin (Ksg, blue) binding are colored red. e-h, View of (e) lincomycin, (f) clindamycin, (g) tiamulin and (h) retapamulin binding site (23S rRNA, grey) in the absence (left panel) and presence of the drug (right panel). Waters (spheres) that are displaced upon binding of the antibiotic are colored red. In (a)-(h), waters (spheres) that are stabilized upon drug binding are colored green.CC BY · PubMed Central
Extended Data Fig 8 Comparisons of pentacycline- and evernimicin-ribosome structures. a, Interaction of pentacycline on the SSU head at 1.89 Å. b-d, Superimposition of pentacycline from (a) with (b) tetracycline on the SSU head determined at 1.8 Å (from Fig. 2), (c) eravacycline on the SSU head determined at 2.2 Å (from Fig. 4), and (d) omadacycline on the SSU head determined at 2.1 Å (from Fig. 4), e-f, Zoom of the coordination of the Mg2 for (e) omadacycline and (f) pentacycline. g, Interaction of evernimicin (Evn) on the LSU at 1.9 Å. h, Superimposition of evernimicin (Evn) from (g) with avilamycin (Avi) (from Fig. 3). i, Superimposition of Evn (blue) from (g) with previous structures of Evn in complex with the ribosome (PDB ID 5KCS and 5JVH)43,44. j, Interaction of iboxamycin (green) on the 70S ribosome at 2.5 Å (PDB ID 7RQ8)46. k-l, superimposition of iboxamycin (green) from (j) with (k) clindamycin (light blue) and (l) lincomycin (dark blue) determined here at 2.0 Å and 1.6 Å, respectively.
Extended Data Fig 8 Comparisons of pentacycline- and evernimicin-ribosome structures. a, Interaction of pentacycline on the SSU head at 1.89 Å. b-d, Superimposition of pentacycline from (a) with (b) tetracycline on the SSU head determined at 1.8 Å (from Fig. 2), (c) eravacycline on the SSU head determined at 2.2 Å (from Fig. 4), and (d) omadacycline on the SSU head determined at 2.1 Å (from Fig. 4), e-f, Zoom of the coordination of the Mg2 for (e) omadacycline and (f) pentacycline. g, Interaction of evernimicin (Evn) on the LSU at 1.9 Å. h, Superimposition of evernimicin (Evn) from (g) with avilamycin (Avi) (from Fig. 3). i, Superimposition of Evn (blue) from (g) with previous structures of Evn in complex with the ribosome (PDB ID 5KCS and 5JVH)43,44. j, Interaction of iboxamycin (green) on the 70S ribosome at 2.5 Å (PDB ID 7RQ8)46. k-l, superimposition of iboxamycin (green) from (j) with (k) clindamycin (light blue) and (l) lincomycin (dark blue) determined here at 2.0 Å and 1.6 Å, respectively.CC BY · PubMed Central
Extended Data Fig. 9 Comparisons of antibiotic-ribosome structures. a-b, Interaction of spectinomycin (Spc) determined (a) here on E. coli (SpcE.coli) at 1.8 Å (from Fig. 2) and (b) on the E. faecalis 70S ribosome (SpcE.fae.) at 2.4 Å8. c, Superimposition of (a) and (b). d-e, Interaction of spectinomycin (Spc) determined (d) here on E. coli (SpcE.coli) at 1.8 Å (from Fig. 2) and (e) within an E. coli translocation intermate (SpcTrans) at 2.54 Å55. f, Superimposition of (d) and (e). g-h, Interaction of apramycin (Apr) determined (g) here on E. coli (AprE.coli) (from Fig. 2) and (h) within an E. coli translocation intermediate (AprTrans) at 2.35 Å7. i, Superimposition of (g) and (h). j-k, Interaction of (j) gentamicin (Gen) determined here on E. coli (Gen) (from Fig. 2) and (k) paromomycin (Par) on an E. coli bearing mRNA, A- and P-site tRNAs at 1.98 Å12. l, Superimposition of (i) and (j).
Extended Data Fig. 9 Comparisons of antibiotic-ribosome structures. a-b, Interaction of spectinomycin (Spc) determined (a) here on E. coli (SpcE.coli) at 1.8 Å (from Fig. 2) and (b) on the E. faecalis 70S ribosome (SpcE.fae.) at 2.4 Å8. c, Superimposition of (a) and (b). d-e, Interaction of spectinomycin (Spc) determined (d) here on E. coli (SpcE.coli) at 1.8 Å (from Fig. 2) and (e) within an E. coli translocation intermate (SpcTrans) at 2.54 Å55. f, Superimposition of (d) and (e). g-h, Interaction of apramycin (Apr) determined (g) here on E. coli (AprE.coli) (from Fig. 2) and (h) within an E. coli translocation intermediate (AprTrans) at 2.35 Å7. i, Superimposition of (g) and (h). j-k, Interaction of (j) gentamicin (Gen) determined here on E. coli (Gen) (from Fig. 2) and (k) paromomycin (Par) on an E. coli bearing mRNA, A- and P-site tRNAs at 1.98 Å12. l, Superimposition of (i) and (j).CC BY · PubMed Central
Extended Data Fig. 10 Testing of parameters of the neural network models. For different numbers of layers and neurons per layer, the RMSE of predicted rmsd values relative to rmsd values obtained from the simulations for the cross-validation sets is shown. Mean (circles) and standard deviations (lines) obtained from training and cross-validation against 10 different training data sets. Colors denote different h-bond types used as input for the networks.
Extended Data Fig. 10 Testing of parameters of the neural network models. For different numbers of layers and neurons per layer, the RMSE of predicted rmsd values relative to rmsd values obtained from the simulations for the cross-validation sets is shown. Mean (circles) and standard deviations (lines) obtained from training and cross-validation against 10 different training data sets. Colors denote different h-bond types used as input for the networks.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 106 references

Cited by

See all 98

Metadata

Authors
Paternoga, H., Crowe-McAuliffe, C., Bock, L. V., Koller, T. O., Morici, M., Beckert, B., Myasnikov, A. G., Grubmüller, H., Nováček, J., & Wilson, D. N.
Affiliations
  • Universität Hamburg (DE)
  • Max Planck Institute for Multidisciplinary Sciences (DE)
  • École Polytechnique Fédérale de Lausanne (CH)
  • Central European Institute of Technology (CZ)
Corresponding author
Wilson, Daniel N.
Venue
Nature Structural & Molecular Biology
Published
2023-08-07
Volume
30
Issue
9
Pages
1380-1392
ISSN
  • 1545-9985 (ISSN-L)
  • 1545-9993
OpenAlex
W4385638623
Cited by
94
References
103
Citations by year
2026: 24 · 2025: 33 · 2024: 36 · 2023: 1
FWCI
8.38
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Structural & Molecular Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, other-oa)
Funders
  • Joint Programming Initiative on Antimicrobial Resistance
  • Deutsche Forschungsgemeinschaft (WI3285/12-1, EXC 2067, EXC 2067‐1, 390729940, EXC 2067/1390729940)
  • Ministerstvo Školství, Mládeže a Tělovýchovy (871037, CZ.02.1.01, LM2023042)
  • Universität Hamburg
  • Central European Institute of Technology
  • European Regional Development Fund (02.1.01/0.0/0.0, CZ.02, CZ.02.1.01, CZ.02.1.01/0.0/0.0)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Keywords
bacterial ribosome, multidrug resistance, cryo-EM structure, ordered water molecules, structural conservation, RNA-ligand interactions, antimicrobial drug design
MeSH terms
Anti-Bacterial Agents, Bacteria, Binding Sites, Ribosomes, RNA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural conservation of antibiotic interaction with ribosomes. https://app.cochat.ai/papers/10.1038/s41594-023-01047-y
The paper
Paternoga, H., Crowe-McAuliffe, C., Bock, L. V., Koller, T. O., Morici, M., Beckert, B., Myasnikov, A. G., Grubmüller, H., Nováček, J., & Wilson, D. N. (2023). Structural conservation of antibiotic interaction with ribosomes. Nature Structural & Molecular Biology. https://doi.org/10.1038/s41594-023-01047-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.